Keyphrases
Virus
100%
Hantavirus
60%
Hantavirus Pulmonary Syndrome
59%
Nipah Virus
41%
Ebola Virus
41%
Rodents
38%
Sin Nombre Virus
27%
Rift Valley Fever
24%
Ebola Hemorrhagic Fever
22%
Quantitative PCR
21%
Rift Valley Fever Virus
20%
Enzyme-linked Immunosorbent Assay (ELISA)
20%
Democratic Republic of Congo
19%
Virus Infection
19%
Hantavirus Infection
19%
United States
17%
Nipah Virus Infection
17%
Southwestern United States
16%
Illness
16%
Arenavirus
15%
Ebola
15%
Serum Samples
14%
Bangladesh
14%
Hemorrhagic Fever
14%
Filovirus
14%
Lymphocytic Choriomeningitis Virus
13%
Marburg Virus
13%
Encephalitis
13%
Kikwit
13%
Virus Antigen
12%
Risk Factors
12%
North America
11%
Malaysia
11%
Virus-neutralizing Antibody
11%
Crimean-Congo Hemorrhagic Fever Virus (CCHFV)
11%
Severe Acute Respiratory Syndrome
11%
Fever
11%
Ebola Virus Infection
11%
Genetic Diversity
11%
Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
10%
Antibody Prevalence
10%
Epidemiology
10%
Philippines
10%
Crimean-Congo Hemorrhagic Fever
10%
Hemorrhagic Fever with Renal Syndrome
10%
Nipah
9%
Human-to-human Transmission
9%
Virus Isolation
9%
Hendra Virus
9%
IgG Antibody
9%
Immunology and Microbiology
Immunology
67%
Hantavirus
59%
Hemorrhagic Fever
58%
Viral Disease
42%
Ebola Virus
40%
Nipah Virus
29%
Prevalence
23%
Rift Valley Fever Virus
19%
Sin Nombre Virus
18%
Arenaviridae
16%
Rift Valley Fever
15%
Enzyme-Linked Immunosorbent Assay
14%
Virus Antigen
13%
Filovirus
13%
Immunoglobulin M
12%
Reverse Transcription Polymerase Chain Reaction
12%
Encephalitis
12%
Glycoprotein
11%
Severe Acute Respiratory Syndrome
11%
Marburgvirus
11%
Antibody Titer
11%
Crimean-Congo Hemorrhagic Fever Virus
10%
Lymphocytic Choriomeningitis Virus
10%
Neutralizing Antibody
9%
Coronavirinae
9%
Lassa Virus
9%
Neutralization
9%
SARS Coronavirus
9%
ELISA
9%
Cell Culture
9%
Monoclonal Antibody
9%
Virus Isolation
9%
Genetic Variability
9%
Immunoglobulin M Antibody
8%
RNA Virus
8%
Lineages
8%
Hendra Virus
8%
Cladistics
8%
Virus Nucleocapsid
7%
Paramyxoviridae
7%
Virus Strain
7%
Zoonotic
6%
Virus Antibody
6%
Haplorhini
6%
Titer
6%
Arenavirus
6%
Infectious Agent
6%
Macaca fascicularis
6%
Quantitative Reverse Transcription Polymerase Chain Reaction
6%
Bunyaviridae
6%
Medicine and Dentistry
Hantavirus Pulmonary Syndrome
38%
Disease
35%
Hantavirus
32%
Infection
29%
Ebolavirus
14%
Ebola Hemorrhagic Fever
13%
Severe Acute Respiratory Syndrome
11%
Hantavirus Infection
11%
Prevalence
10%
Sin Nombre Virus
9%
Virus Infection
9%
Rift Valley Fever
8%
Coronavirinae
8%
Nipah Virus
8%
Viral Hemorrhagic Fever
8%
Reverse Transcription Polymerase Chain Reaction
7%
Lymphocytic Choriomeningitis Virus
6%
Crimean-Congo Hemorrhagic Fever
5%
Diagnosis
5%
SARS Coronavirus
5%
Respiratory Disease
5%
Rift Valley Fever Virus
5%
Encephalitis
5%
Antiporter
5%
Public Health
5%
Virus Antigen
5%